NAMS
NewAmsterdam Pharma·NASDAQ
--
--(--)
--
--(--)
NAMS fundamentals
NewAmsterdam Pharma (NAMS) released its earnings on Aug 6, 2025: revenue was 19.14M (YoY +740.06%), beat estimates; EPS was -0.15 (YoY +63.41%), beat estimates.
Revenue / YoY
19.14M
+740.06%
EPS / YoY
-0.15
+63.41%
Report date
Aug 6, 2025
Earnings Call
7:00 AM on Aug 6, 2025
Meeting link.EPS
Actual | -0.41 | -0.93 | -0.345 | -0.15 | |||
Forecast | -0.5768 | -0.4862 | -0.492 | -0.4632 | |||
Surprise | 0.00% | 0.00% | 0.00% | +28.92% | -91.28% | +29.88% | +67.62% |
Revenue
Actual | -- | -- | -- | 2.28M | 12.80M | 3.00M | 19.14M |
Forecast | -- | -- | -- | 1.21M | 1.76M | 1.56M | 3.49M |
Surprise | 0.00% | 0.00% | 0.00% | +88.97% | +629.09% | +91.81% | +447.99% |
Earnings Call
You can ask Aime
What were the key takeaways from NewAmsterdam Pharma’s earnings call?What is the revenue and EPS growth rate for NewAmsterdam Pharma year over year?What were the key takeaways from NewAmsterdam Pharma's earnings call?What does NewAmsterdam Pharma do and what are its main business segments?What is NewAmsterdam Pharma's latest dividend and current dividend yield?What guidance did NewAmsterdam Pharma's management provide for the next earnings period?What factors drove the changes in NewAmsterdam Pharma's revenue and profit?What is NewAmsterdam Pharma's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
